共 50 条
PET-Computed Tomography in Head and Neck Cancer Current Evidence and Future Directions
被引:9
|作者:
Chen, Yin Jie
[1
]
Rath, Tanya
[2
,3
]
Mohan, Suyash
[4
]
机构:
[1] Univ Penn, Perelman Sch Med, Dept Radiol, Hosp Univ Penn, 1 Silverstein,3400 Spruce St, Philadelphia, PA 19104 USA
[2] Univ Pittsburgh, Sch Med, Dept Radiol, Radiol Adm, PUH Suite E204,200 Lothrop St, Pittsburgh, PA 15213 USA
[3] Univ Pittsburgh, Sch Med, Dept Otolaryngol, Radiol Adm, PUH Suite E204,200 Lothrop St, Pittsburgh, PA 15213 USA
[4] Univ Penn, Perelman Sch Med, Hosp Univ Penn, Dept Radiol, 219 Dulles Bldg,3400 Spruce St, Philadelphia, PA 19104 USA
关键词:
Head and neck;
Squamous cell carcinoma;
HNSCC;
FDG;
PET;
PET-CT;
POSITRON-EMISSION-TOMOGRAPHY;
SQUAMOUS-CELL CARCINOMA;
INTENSITY-MODULATED RADIOTHERAPY;
PET/CONTRAST-ENHANCED CT;
LYMPH-NODE METASTASES;
FDG-PET;
F-18-FDG PET/CT;
TUMOR HYPOXIA;
DISTANT METASTASES;
PREDICTIVE-VALUE;
D O I:
10.1016/j.mric.2017.08.003
中图分类号:
R8 [特种医学];
R445 [影像诊断学];
学科分类号:
1002 ;
100207 ;
1009 ;
摘要:
Head and neck cancers are among the most common cancers worldwide. More than 90% to 95% are squamous cell carcinomas (SCCs). Accurate staging at diagnosis optimizes treatment planning with improved outcomes. 18F-fluorodeoxyglucose (FDG) PET-computed tomography (CT) has shown tremendous value at diagnosis for accurate staging, treatment planning, and prognostication and after definitive therapy for assessing response and long-term surveillance. Novel non-FDG PET tracers are under investigation, which have great potential for improving patient care in this era of personalized medicine.
引用
收藏
页码:37 / +
页数:14
相关论文